Volta Labs and Watchmaker Genomics Partner to Simplify and Optimize NGS Library Prep

Partnership

Volta Labs, a genomics applications company, and Watchmaker Genomics, a supplier of innovative products for molecular analysis, partner to leverage their technologies to power Volta’s short-read library prep kits.

Committment

Volta Labs and Watchmaker Genomics are jointly committed to making efficient, accessible, and cost-effective library prep a reality. With the launch of Volta’s Callisto™ Sample Prep System, Watchmaker Genomics will provide the reagents behind various VoltaPrep™ library prep kits.

Trey Foskett, CEO of Watchmaker Genomics

“Volta’s digital fluidics technology and their approach to building automated sample prep applications are impressive. Watchmaker has a passion for delivering superior data quality with simple and automatable workflows. Combining Volta’s cutting-edge technology with our innovative reagents delivers in both of these areas, and we look forward to a continued partnership.”

Udayan Umapathi, CEO at Volta Labs

“Watchmaker has set the bar high for enzyme engineering and library prep workflow development. We are energized to work with their talented team to address quality, cost, and scalability challenges that currently exist in sample prep. This collaboration is the first in a series of Volta applications that will be powered by Watchmaker chemistry.”

Callisto™ Sample Prep System

The Callisto™ Sample Prep System offers programmable, precise, and plastic-free liquid manipulation with pre-optimized applications to support short- and long-read sequencing workflows. With a growing menu of library prep kits powered by Watchmaker Genomics’ solutions, Volta will continue to expand the universe of pre-optimized applications available through Callisto and enable labs to maximize advancements in sequencing.

Sourceolta Labs
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Michael Dabrowski, CEO of Pelago Bioscience "We are grateful to the University of Edinburgh in their acknowledgement of our Patent. I encourage the drug discovery community to engage with Pelago Bioscience to explore the value that our patented CETSA technology and services can bring to enhance their drug discovery efforts.
The Thermo Scientific™ Dionex™ Inuvion™ Ion Chromatography (IC) system, helping to make ion analysis simpler and more intuitive for labs of all sizes. The new analytical instrument is designed to be easily reconfigurable, providing those who require determination of ionic and small polar compounds with a one stop shop for consistent, reliable ion analysis.
This new collaboration is another example of Blacksmith's creative deal-making with top tier partners that bring expertise to the table which helps de-risk and accelerate scientific discoveries for the development of valuable products.
Heparin Sodium 2,000 units in 0.9% Sodium Chloride Injection 1,000 mL (2 units/mL), is indicated as an anticoagulant to maintain catheter patency.
Through this agreement, RaySearch acquires full ownership of all rights to the product DrugLog for its application in the field of oncology, including the measuring device, calibration parameters, source code, as well as intellectual property rights.

By using this website you agree to accept Medical Device News Magazine Privacy Policy